Krassimir Mitchev has held various high-level positions in several pharmaceutical companies, including Calliditas Therapeutics, Arden Regulatory Clinical & Medical Consulting Limited, Santhera Pharmaceuticals, Sobi, GlaxoSmithKline, and UCB Pharma. Throughout their career, Krassimir has been involved in therapeutic area development, medical leadership, global medical strategy, stakeholder engagement, alliance partner management, evidence generation planning, and clinical study design and execution. Mitchev has played a crucial role in the successful launches of innovative medicines and has contributed as a medical expert to various business development activities within the industry.
June, 2022 - present
August, 2020
December, 2019